Achillion Pharmaceuticals CEO Joseph Truitt's 2018 pay jumps 209% to $3.3M

Achillion Pharmaceuticals reports 2018 executive compensation

Published: April 15, 2019

Achillion Pharmaceuticals reported fiscal year 2018 executive compensation information on April 15, 2019.

In 2018, six executives at Achillion Pharmaceuticals received on average a compensation package of $1.6M, a 15% increase compared to previous year.

Average pay of disclosed executives at Achillion Pharmaceuticals

Joseph Truitt, Chief Executive Officer, received $3.3M in total, which increased by 209% compared to 2017. 76.38% of Truitt's compensation, or $2.5M, was in option awards. Truitt also received $255.6K in non-equity incentive plan, $509.4K in salary, as well as $8.7K in other compensation.

Milind Deshpande, Chief Executive Officer, received a compensation package of $2.1M, which decreased by 6% compared to previous year. 62.61% of the compensation package, or $1.3M, was in option awards.

Steven Zelenkofske, Chief Medical Officer, earned $1.2M in 2018.

Paul Firuta, Chief Operating Officer, received $1.1M in 2018.

Mary Kay Fenton, Chief Financial Officer, earned $1.1M in 2018, a 9% increase compared to previous year.

Anthony Gibney, Executive Vice President and Chief Business Officer, received $1.1M in 2018.